Abstract:Background: Managing healing of impaired bone fracture has long been a subject of concern. Prolonged or uncontrolled inflammation exerts detrimental effects on bone healing. Tμmor necrosis factor (TNF)-α is a critical inflammatory factor, whose absence impairs normal bone formation. However, TNF-α exposure for longer duration inhibits bone regeneration. In this study, we aim to find a new therapeutic target for the impaired osteogenesis induced by long exposure of TNF-α.Methods: In vitro, mRNA microarray analysis was used to identify differentially expressed genes. Cell proliferation assay was used to assess the proliferation of cells. qPCR and Western blotting analysis were applied to detect the expression of target genes and proteins respectively. ALP staining and Alizarin Red staining (ARS) were used to evaluate ALP activity and mineral deposition respectively. Co-immunoprecipitation was used to detect the interaction of proteins. In vitro , a murine tibial fracture model was established, histological evaluation and radiographic analysis was used to confirm bone regeneration in fracture healing. statistical significance between two groups was determined by Student’s t test, one-way ANOVA or Bonferroni’s post-hoc test according to the distribution of the tested population.Results: In this study, we show that heat shock protein family B (small) member 7 (HSPB7) mitigates negative impact of long-term TNF-α exposure on bone formation by binding heat shock protein family H (small) member 1 (HSPH1). HSPH1, in turn, inhibits the ATPase of heat shock cognate A8 (HSCA8), one of the key components involved in chaperone-mediated autophagy (CMA). Deletion of genes encoding for either HSCA8 or lysosome-associated membrane protein 2A (LAMP2A), another component of CMA, failed to reverse the osteogenic differentiation of hBMSCs induced by TNF-α by deleting HSPH1.Subsequently, transcriptome analysis was further used to explore downstream related pathways mediated by CMA. After LAMP2a gene knockdown, transcriptional analysis showed that the PI3K/AKT/GSK3β signaling pathway was significantly inhibited. LAMP2A overexpression reverse the impaired osteogenesis induced by TNF-α, and this effect was attenuated by DKK1, a specific Wnt/β-catenin signaling pathway inhibitors. Finally, we successfully constructed a mouse tibial fracture model and locally injected TNF-α to simulate the chronic inflammatory environment. Histological and imaging results showed that TNF-α significantly inhibited fracture healing, while the addition of HSPB7 overexpressed lentivirus successfully saved fracture healing. Thus, a heat shock protein family network composed by HAPB7, HSPH1 and HSCA8 rescued the impairment of bone healing by TNF-α through the CMA-mediated PI3K/AKT/GSK3β signaling pathway., making it a potential therapeutic agent for bone regeneration in cases of prolonged or severe inflammation in the clinical settings.Conclusions: Taken together, these findings indicate that a heat shock protein family network including HSPB7, HSPH1 and HSCA8 protects the impaired osteogenesis induced by TNF-α via CMA through PI3K/AKT/GSK3β/β-catenin pathway. And in vivo, HSPB7 overexpression lentiviral particles effectively protects the impaired fracture healing induced by TNF-α in a mouse tibia fracture healing model.Funding: This work was supported by grants from the National Natural Science Foundation of China (Nos. 81672147; Nos. 81874007).Declaration of Interest: The authors declare no conflicts of interest.Ethical Approval: All animal experiments were in accordance to the Animal Care and Use Committee guidelines of Zhejiang University. All experimental procedures were in accordance with the and Institutional Animal Care Use Committee at Zhejiang University.

Dynamic control of mTORC1 facilitates bone healing in mice

Mtorc1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, in Vitro and in Mice

Reversing the Imbalance in Bone Homeostasis Via Sustained Release of SIRT-1 Agonist to Promote Bone Healing under Osteoporotic Condition

mTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation

Inactivation of Regulatory-associated Protein of Mtor (raptor)/mammalian Target of Rapamycin Complex 1 (mtorc1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.

mTORC1 Prevents Preosteoblast Differentiation through the Notch Signaling Pathway

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

Rapamycin facilitates the tendon-bone interface healing in an aging rat model of chronic rotator cuff injury

Activation of Mtorc1 in Subchondral Bone Preosteoblasts Promotes Osteoarthritis by Stimulating Bone Sclerosis and Secretion of CXCL12

The mTORC2 Component Rictor Is Required for Load-Induced Bone Formation in Late-Stage Skeletal Cells

Investigation of the effectiveness of intermittent electromagnetic field stimulation for early internal cartilaginous ossification in prechondrocytic ATDC5 cells

HSPB7 Protects Bone Formation from TNF-α Via Chaperone Mediated Autophagy Through PI3K/AKT/GSK3β/Β-Catenin Pathway

The Effect of Rapamycin on Bone Growth in Rabbits.

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of Mtorc1 in Osteoclast Formation.

mTORC1 coordinates NF-κB signaling pathway to promote chondrogenic differentiation of tendon cells in heterotopic ossification

Rapamycin Improves Bone Mass in High-Turnover Osteoporosis with Iron Accumulation Through Positive Effects on Osteogenesis and Angiogenesis.

MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2

Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and Osteoclasts

Rapamycin Prevents Heterotopic Ossification By Inhibiting The Mtor Pathway And Oxidative Stress

Tanshinone IIA Regulates Osteoblast Differentiation and Promotes Fracture Healing via Mammalian Target of Rapamycin Complex 1 Signaling Pathway